Franklin Resources Inc Enanta Pharmaceuticals Inc Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

A detailed history of Franklin Resources Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 26,179 shares of ENTA stock, worth $325,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,179
Previous 29,066 9.93%
Holding current value
$325,404
Previous $507,000 33.14%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $32,998 - $49,136
-2,887 Reduced 9.93%
26,179 $339,000
Q1 2024

May 13, 2024
BUY
$10.08 - $17.46 $292,985 - $507,492
29,066 New
29,066 $507,000
Q1 2023

May 12, 2023
SELL
$38.82 - $54.59 $1,203 - $1,692
-31 Reduced 0.62%
4,994 $201,000
Q4 2022

Feb 10, 2023
SELL
$40.77 - $53.73 $38,813 - $51,150
-952 Reduced 15.93%
5,025 $233,000
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $288,629 - $425,980
5,977 New
5,977 $309,000
Q1 2022

May 13, 2022
SELL
$56.06 - $74.11 $154,781 - $204,617
-2,761 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$60.19 - $97.37 $166,184 - $268,838
2,761 New
2,761 $206,000
Q3 2018

Nov 13, 2018
SELL
$85.46 - $126.37 $22.9 Million - $33.9 Million
-268,025 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$81.85 - $120.51 $1.45 Million - $2.14 Million
-17,775 Reduced 6.22%
268,025 $31.1 Million
Q1 2018

May 10, 2018
SELL
$57.91 - $92.15 $1.85 Million - $2.94 Million
-31,900 Reduced 10.04%
285,800 $23.1 Million
Q4 2017

Feb 14, 2018
BUY
$45.65 - $59.37 $5.37 Million - $6.99 Million
117,700 Added 58.85%
317,700 $18.6 Million
Q3 2017

Nov 13, 2017
BUY
$37.91 - $46.8 $7.58 Million - $9.36 Million
200,000
200,000 $9.36 Million

Others Institutions Holding ENTA

# of Institutions
99
Shares Held
21.2M
Call Options Held
10.4K
Put Options Held
2.3K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $258M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email